Review of the Ocular Angiogenesis Animal Models

REFERENCES

• Michaelson I C. The mode of development of the vascular system of the retina. With some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948; 68: 137
   Google Scholar
• Patz A. Retinal neovascularisation: Early contributions of Professor Michaelson and recent observations. British Journal of Ophthalmology 1984; 68: 42–46
   Google Scholar
• Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 1954; 38: 397–432
   PubMed Web of Science ®Google Scholar
• Ashton N. Animal experiments in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 1954; 58: 51–3, discussion, 53–4
   PubMedGoogle Scholar
• Gyllensten L J, Hellstrom B E. Experimental approach to the pathogenesis of retrolental fibroplasia. I. Changes of the eye induced by exposure of newborn mice to concentrated oxygen. Acta Paediatr Suppl 1954; 43: 131–148
   Google Scholar
• Imre G. Studies on the mechanism of retinal neovascularization. Role of lactic acid. Br J Ophthalmol 1964; 48: 75–82
   PubMedGoogle Scholar
• Baum J L, Wise G N. Experimental subretinal neovascularization. Transactions of the American Ophthalmological Society 1965; 63: 91–107
   Google Scholar
• Cogan D G. Vascularization of the cornea; ats experimental induction by small lesions and a new theory of its pathogenesis. Archives of Ophthalmology 1949; 41: 406–416
   Google Scholar
• Maurice D M, Zauberman H, Michaelson I C. The stimulus to neovascularization in the cornea. Exp Eye Res 1966; 5: 168–184
   PubMed Web of Science ®Google Scholar
• Gimbrone M A, Leapman S B, Cotran R S, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972; 136: 261–276
   PubMed Web of Science ®Google Scholar
• Gimbrone M A, Jr., Cotran R S, Leapman S B, Folkman J. Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974; 52: 413–427
   PubMed Web of Science ®Google Scholar
• Shing Y, Folkman J, Haudenschild C, Lund D, Crum R, Klagsbrun M. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Biochem 1985; 29: 275–287
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447
   PubMed Web of Science ®Google Scholar
• Rogers M S, Birsner A E, D'Amato R J. The mouse cornea micropocket angiogenesis assay. Nat Protoc 2007; 2: 2545–2550
   PubMed Web of Science ®Google Scholar
• Ausprunk D H, Knighton D R, Folkman J. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol 1975; 79: 597–618
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis factor. Cancer Res 1974; 34: 2109–2113
   PubMed Web of Science ®Google Scholar
• Ryan S J. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 1979; 77: 707–745
   PubMedGoogle Scholar
• Ryan S J. Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol 1982; 100: 1804–1809
   PubMedGoogle Scholar
• Miller H, Miller B. Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch Ophthalmol 1993; 111: 855–860
   PubMed Web of Science ®Google Scholar
• Miller J W, Walsh A W, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995; 113: 810–818
   PubMed Web of Science ®Google Scholar
• Virdi P S, Hayreh S S. Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. Arch Ophthalmol 1982; 100: 331–341
   PubMed Web of Science ®Google Scholar
• Hayreh S S, Lata G F. Ocular neovascularization. Experimental animal model and studies on angiogenic factor(s). Int Ophthalmol 1986; 9: 109–120
   Google Scholar
• Packer A J, Gu X Q, Servais E G, Hayreh S S. Primate model of neovascular glaucoma. Int Ophthalmol 1986; 9: 121–127
   Google Scholar
• Miller J W, Adamis A P, Shima D T, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574–584
   PubMed Web of Science ®Google Scholar
• Pierce E A, Avery R L, Foley E D, Aiello L P, Smith L E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92: 905–909
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997; 235: 159–167
   PubMed Web of Science ®Google Scholar
• Pierce E A, Foley E D, Smith L E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996; 114: 1219–1228
   PubMedGoogle Scholar
• Kang S G, Chung H, Hyon J Y. Experimental preretinal neovascularization by laser-induced thrombosis in albino rats. Korean J Ophthalmol 1999; 13: 65–70
   Google Scholar
• Saito Y, Park L, Skolik S A, et al. Experimental preretinal neovascularization by laser-induced venous thrombosis in rats. Curr Eye Res 1997; 16: 26–33
   Web of Science ®Google Scholar
• Shen W, He S, Han S, Ma Z. Preretinal neovascularisation induced by photodynamic venous thrombosis in pigmented rat. Aust N Z J Ophthalmol 1996; 24: 50–52
   Google Scholar
• Zauberman H, Michaelson I C, Bergmann F, Maurice D M. Stimulation of neovascularization of the cornea by biogenic amines. Exp Eye Res 1969; 8: 77–83
   Google Scholar
• Kenyon B M, Voest E E, Chen C C, Flynn E, Folkman J, D'Amato R J. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996; 37: 1625–1632
   PubMed Web of Science ®Google Scholar
• Loughman M S, Chatzistefanou K, Gonzalez E M, et al. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust N Z J Ophthalmol 1996; 24: 289–295
   PubMedGoogle Scholar
• Corrent G, Roussel T J, Tseng S C, Watson B D. Promotion of graft survival by photothrombotic occlusion of corneal neovascularization. Arch Ophthalmol 1989; 107: 1501–1506
   Google Scholar
• Williams K A, Grutzmacher R D, Roussel T J, Coster D J. A comparison of the effects of topical cyclosporine and topical steroid on rabbit corneal allograft rejection. Transplantation 1985; 39: 242–244
   PubMed Web of Science ®Google Scholar
• Usui T, Yamagami S, Kishimoto S, Seiich Y, Nakayama T, Amano S. Role of macrophage migration inhibitory factor in corneal neovascularization. Invest Ophthalmol Vis Sci 2007; 48: 3545–3550
   PubMed Web of Science ®Google Scholar
• Ambati B K, Joussen A M, Kuziel W A, Adamis A P, Baum A J. Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 2003; 22: 465–467
   PubMed Web of Science ®Google Scholar
• Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F. Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis. Clin Experiment Ophthalmol 2007; 35: 745–748
   PubMed Web of Science ®Google Scholar
• Azar D T. Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2006; 104: 264–302
   PubMedGoogle Scholar
• Moromizato Y, Stechschulte S, Miyamoto K, et al. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol 2000; 157: 1277–1281
   Google Scholar
• Francois J, De Laey J J, Cambie E, Hanssens M, Victoria-Troncoso V. Neovascularization after argon laser photocoagulation of macular lesions. Am J Ophthalmol 1975; 79: 206–210
   PubMed Web of Science ®Google Scholar
• Fine S L, Patz A, Orth D H, Klein M L, Finkelstein D, Yassur Y. Subretinal neovascularization developing after prophylactic argon laser photocoagulation of atrophic macular scars. Am J Ophthalmol 1976; 82: 352–357
   Web of Science ®Google Scholar
• Archer D B, Gardiner T A. Morphologic fluorescein angiographic, and light microscopic features of experimental choroidal neovascularization. Am J Ophthalmol 1981; 91: 297–311
   PubMedGoogle Scholar
• Archer D B, Gardiner T A. Electron microscopic features of experimental choroidal neovascularization. Am J Ophthalmol 1981; 91: 433–457
   Google Scholar
• elDirini A A, Ogden T E, Ryan S J. Subretinal endophotocoagulation. A new model of subretinal neovascularization in the rabbit. Retina 1991; 11: 244–249
   PubMed Web of Science ®Google Scholar
• Dobi E T, Puliafito C A, Destro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol 1989; 107: 264–269
   PubMedGoogle Scholar
• Frank R N, Das A, Weber M L. A model of subretinal neovascularization in the pigmented rat. Curr Eye Res 1989; 8: 239–247
   PubMed Web of Science ®Google Scholar
• Tobe T, Ortega S, Luna J D, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998; 153: 1641–1646
   PubMed Web of Science ®Google Scholar
• Campa C, Kasman I, Ye W, Lee W, Fuh G, Ferrara N. Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: Optimizing methods to quantify vascular changes. Investigative Ophthalmology & Visual Science 2008; 49: 1178–1183
   Google Scholar
• Lassota N, Kiilgaard J F, la Cour M, Scherfig E, Prause J U. Natural history of choroidal neovascularization after surgical induction in an animal model. Acta Ophthalmol 2008; 86: 495–503
   PubMed Web of Science ®Google Scholar
• Krzystolik M G, Afshari M A, Adamis A P, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Archives of Ophthalmology 2002; 120: 338–346
   PubMed Web of Science ®Google Scholar
• Marneros A G, She H, Zambarakji H, et al. Endogenous endostatin inhibits choroidal neovascularization. The FASEB Journal 2007; 21: 3809–3818
   PubMed Web of Science ®Google Scholar
• D'amato R, Wesolowski E, Smith L E. Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvascular Research 1993; 46: 135–142
   PubMed Web of Science ®Google Scholar
• Lassota N, Kiilgaard J F, Prause J U, Qvortrup K, Scherfig E, la Cour M. Surgical induction of choroidal neovascularization in a porcine model. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1189–1198
   PubMed Web of Science ®Google Scholar
• Kimura H, Sakamoto T, Hinton D R, et al. A new model of subretinal neovascularization in the rabbit. Investigative Ophthalmology & Visual Science 1995; 36: 2110–2119
   PubMed Web of Science ®Google Scholar
• Ni M, Holland M, Jarstadmarken H, De Vries G. Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: Clinical and histological evaluation. Exp Eye Res 2005; 81: 286–297
   PubMed Web of Science ®Google Scholar
• Zhu Z R, Goodnight R, Sorgente N, Ogden T E, Ryan S J. Experimental subretinal neovascularization in the rabbit. Graefes Arch Clin Exp Ophthalmol 1989; 227: 257–262
   Google Scholar
• Qiu G, Stewart J, Sadda S, et al. A new model of experimental subretinal neovascularization in the rabbit. Experimental Eye Research 2006; 83: 141–152
   PubMed Web of Science ®Google Scholar
• Framme C, Sachs H G, Kobuch K, Flucke B, Birngruber R. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad. Ophthalmologica 2008; 222: 254–264
   Google Scholar
• Tano Y, Chandler D B, Machemer R. Retinal neovascularization after intravitreal fibroblast injection. Am J Ophthalmol 1981; 92: 103–109
   PubMed Web of Science ®Google Scholar
• Antoszyk A N, Gottlieb J L, Machemer R, Hatchell D L. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993; 231: 34–40
   PubMed Web of Science ®Google Scholar
• Rakoczy P E, Brankov M, Fonceca A, Zaknich T, Rae B C, Lai C M. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: A potential model for diabetic retinopathy. Diabetes 2003; 52: 857–863
   PubMed Web of Science ®Google Scholar
• Okamoto N, Tobe T, Hackett S F, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151: 281–291
   PubMed Web of Science ®Google Scholar
• Miller J W. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 1997; 151: 13–23
   PubMed Web of Science ®Google Scholar
• Tobe T, Okamoto N, Vinores M A, et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 1998; 39: 180–188
   PubMed Web of Science ®Google Scholar
• Ohno-Matsui K, Hirose A, Yamamoto S, et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 2002; 160: 711–719
   PubMed Web of Science ®Google Scholar
• Lai C M, Dunlop S A, May L A, et al. Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol 2005; 89: 911–916
   PubMed Web of Science ®Google Scholar
• Ricci B. Oxygen-induced retinopathy in the rat model. Doc Ophthalmol 1990; 74: 171–177
   PubMedGoogle Scholar
• Holmes J M, Zhang S, Leske D A, Lanier W L. The effect of carbon dioxide on oxygen-induced retinopathy in the neonatal rat. Curr Eye Res 1997; 16: 725–732
   PubMed Web of Science ®Google Scholar
• Holmes J M, Duffner L A. The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr Eye Res 1996; 15: 403–409
   PubMed Web of Science ®Google Scholar
• Smith L E, Wesolowski E, Mclellan A, et al. Oxygen-induced retinopathy in the mouse. Investigative Ophthalmology & Visual Science 1994; 35: 101–111
   PubMed Web of Science ®Google Scholar
• Brooks S E, Gu X, Samuel S, et al. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Investigative Ophthalmology & Visual Science 2001; 42: 222–228
   PubMed Web of Science ®Google Scholar
• McLeod D S, Brownstein R, Lutty G A. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 1996; 37: 300–311
   PubMed Web of Science ®Google Scholar
• Cao R, Jensen L, Söll I, Hauptmann G, Cao Y. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy. PLoS ONE 2008; 3: e2748
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Sanui H, Ishibashi T, et al. Subretinal neovascularization in the rat induced by IRBP synthetic peptides. Exp Eye Res 1994; 58: 155–160
   Google Scholar
• Stallard H B. The histological appearances of an eye successfully treated by diathermy for retinal detachment. Fatal termination from pulmonary thrombosis on the nineteenth day after operation. Br J Ophthalmol 1933; 17: 294–297
   Google Scholar
• Irvine A R, Wood I S. Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis. Am J Ophthalmol 1987; 103: 790–797
   PubMed Web of Science ®Google Scholar
• Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275–288
   PubMed Web of Science ®Google Scholar
• Waisbourd M, Loewenstein A, Goldstein M, Leibovitch I. Targeting vascular endothelial growth factor: A promising strategy for treating age-related macular degeneration. Drugs Aging 2007; 24: 643–662
   PubMed Web of Science ®Google Scholar
• Ferrara N, Mass R D, Campa C, Kim R. Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 2007; 58: 491–504
   PubMed Web of Science ®Google Scholar
• Barouch F C, Miller J W. Potential future targets for treating ocular neovascularization. Ophthalmol Clin North Am 2006; 19: 401–409
   PubMedGoogle Scholar
• Renno R Z, Youssri A I, Michaud N, Gragoudas E S, Miller J W. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002; 43: 1574–1580
   PubMed Web of Science ®Google Scholar
• Kim I K, Husain D, Michaud N, et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci 2006; 47: 357–363
   PubMed Web of Science ®Google Scholar
• Husain D, Kim I, Gauthier D, et al. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol 2005; 123: 509–516
   PubMed Web of Science ®Google Scholar